INCR240517C7500
- 0.04
- 0.000.00%
InterCure Newsroom
CRVS, CTMX and NRXP Are Among Premarket Gainers
InterCure Reports FY Results
Intercure Ltd. Files April SEC Report
Express News | InterCure FY23 Revenue NIS356M
Express News | InterCure Ltd - Expects Sequential Double Digit Quarterly Growth During 2024
Press Release: InterCure Announces FY2023 Results: Revenue of NIS 356 Million and Adjusted EBITDA of NIS 61 Million
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million -- Revenues during 2023 reached NIS 356 million, alongside an Adjusted EBITDA1 of NIS 61
WIRE, CUTR and USEG Are Among Premarket Gainers
Intercure Ltd. Submits SEC Compliance Report
Express News | InterCure Announces Preliminary 2023 Revenue Of NIS 351 Million And EBITDA Of Over NIS 50 Million
Press Release: InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 Million and EBITDA of Over NIS 50 Million
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million -- Revenues for H2 2023 were affected by damages caused by the terrorist attack o
InterCure Congratulates Germany on Cannabis Reform, Expanding Its Global Footprint
InterCure provides an update following recent Cannabis Reform in Germany Expects to launch its first products in Germany in the coming months The Company continues to closely watch developments surrounding
InterCure Advances Restoration of Israeli Site Amid Conflict
InterCure Restoring Facility Near Israel-Gaza Border
By Denny Jacob InterCure, which does business as Canndoc, has begun the process of restoring a facility near the Israel-Gaza border and that they are advancing according to its plans. The medical ca
InterCure Provides an Update Regarding Nir Oz Facility
NEW YORK, and HERZLIYA, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ:INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel
InterCure to Buy Isreal-based Leon Cannabis Pharmacy Chain
InterCure Will Issue 1,755,000 to 1,845,000 Shrs of the Co to the Sellers, Depending on the Shr Price of the Co at the Time of Completion >INCR
InterCure Will Issue 1,755,000 to 1,845,000 Shrs of the Co to the Sellers, Depending on the Shr Price of the Co at the Time of Completion >INCR
Press Release: InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain NEW YORK, and HERZLIYA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc)
Express News | InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain; At Closing, InterCure Will Cause Between 1,755,000 To 1,845,000 Shares Of The Company To Be Issued To The Sellers, Depending On The Share Price Of The Company At The Time Of Com
WKEY, INCR and ZJYL Are Among Pre Market Gainers
Analysts' Opinions Are Mixed on These Healthcare Stocks: 60 Degrees Pharmaceuticals, Inc. (SXTP), Arcturus Therapeutics (ARCT) and Intercure (INCR)